REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Ix Biotron del Ecuador CIA Ltda (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Ix Biotron del Ecuador CIA Ltda Profile Updated: April 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Ix Biotron del Ecuador CIA Ltda is based in Ecuador. The head office is in Quito. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on July 17, 1991. It currently has a total number of 16 (2023) employees. There was a net sales revenue increase of 90.8% reported in Ix Biotron del Ecuador CIA Ltda’s latest financial highlights for 2023. Over the same period, its total assets decreased by 0.09%. The enterprise’s net profit margin increased by 4.97% in 2023.

Headquarters
la Isla N 26-222, Edificio Bldg. , Floor 1
Quito; Pichincha;

Contact Details: Purchase the Ix Biotron del Ecuador CIA Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Ix Biotron del Ecuador CIA Ltda report to view the information.
Outstanding Shares:
Purchase the Ix Biotron del Ecuador CIA Ltda report to view the information.
Registered Capital:
Purchase the Ix Biotron del Ecuador CIA Ltda report to view the information.
Incorporation Date:
July 17, 1991
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
80.01%
Purchase this report to view the information.
10%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Ix Biotron del Ecuador CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
90.8%▲
Total operating revenue
90.8%▲
Operating profit (EBIT)
-20.83%▼
EBITDA
-18.5%▼
Net Profit (Loss) for the Period
274.9%▲
Total assets
-0.09%▼
Total equity
43.78%▲
Operating Profit Margin (ROS)
-23.33%▼
Net Profit Margin
4.97%▲
Return on Equity (ROE)
28.19%▲
Debt to Equity Ratio
-8.87%▼
Quick Ratio
0.38%▲
Cash Ratio
0.12%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo